• The Connectivity Factor: How Interoperability, via AI Agents, Speeds Precision Medicine

    Clinical Research News | What if trial timelines could be cut by years—just by improving how R&D systems and ecosystems talk to each other? In a recent study using generative AI (GAI) to aid decision-making from an integrated data ecosystem, trials sped up by more than 12 months.

    Jul 25, 2025

  • AI-Powered Cell Mapping Could Transform Precision Oncology and Accelerate Clinical Trials

    Clinical Research News | Scientists at Virginia Commonwealth University (VCU) are tackling the massive computational problem of determining the distinct types of cells inhabiting biopsied tissue. Their endgame is to deploy a suite of interoperable artificial intelligence (AI) tools that can accurately and reliably guide prescribing decisions for patients with cancer as well as predict their response to investigational treatments prior to enrollment.

    Jul 22, 2025

  • How ‘Living’ Datasets Will Shape the Future of Precision Medicine

    Clinical Research News | Imagine trying to piece together a puzzle with half the pieces missing—that’s what happens when data is siloed. Without integrated, centralized data across sources, data decisions are made using incomplete, fragmented datasets.

    Jul 18, 2025

  • New Kind of Trial Tests Multiomics-Based Therapy Predictions

    Clinical Research News | As gastrointestinal (GI) trials grow more sophisticated, the volume, velocity, and variety of study data have all expanded. One of the fastest-growing streams is electronic patient-reported outcomes (ePROs): diaries, symptom scores, quality-of-life surveys, and other instruments that come straight from the participant. Collecting this data quickly and conveniently is now mission critical.

    Jul 17, 2025

  • Novel Blood Test Offers Early Cancer Treatment Response Monitoring in Clinical Trials

    Clinical Research News | A fragmentation-based blood test is providing pharmaceutical companies with a new way to monitor cancer treatment response in clinical trials, informing how drug efficacy is evaluated in early-stage development. Delfi Diagnostics has developed DELFI-TF (DELFI-tumor fraction), a research-grade assay that uses a unique fragmentation approach to detect circulating tumor DNA in blood samples.

    Jul 15, 2025

  • Smarter Starts, Stronger Trials: How Data is Driving Faster Site Activation

    Clinical Research News | Feasibility, site selection, and study startup remain some of the most time-consuming and unpredictable phases of drug development. They are also tightly interconnected, making even small delays or inefficiencies during this period especially impactful, rippling across a study’s timeline and budget and affecting site relationships and patient access.

    Jul 11, 2025

  • Scope of Things: Pragmatic Trials’ Growing Importance

    Clinical Research News | The growing importance of pragmatic clinical trials in healthcare research cannot be overstated. In the most recent episode of the Scope of Things podcast, host Deborah Borfitz speaks with Bethany Kwan, University of Colorado Anschutz Medical Campus, and Heather Smyth, Colorado School of Public Health. Together they explore the fundamental distinctions between traditional clinical trials and pragmatic research approaches, uncovering why this methodology is experiencing such significant growth in modern healthcare research.

    Jul 9, 2025